Autres langues Innoveren Scientific Inc.

Actions

IVRN

US4041243076

Temps Différé OTC Markets Autres places de cotation 17:46:52 17/04/2024			Varia. 5j.	Varia. 1 janv.
0,02 ^USD	-33,33%		0,00%	-82,76%

06/03	Innoveren Scientific annonce le dépôt d'une demande 510(K) auprès de la Federal Food and Drug Administration américaine pour le Skindisc(Tm) Lite	CI
2023	Innoveren Scientific Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	06/03
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/11
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	10/07/23
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	10/07/23
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10/05/23
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	10/05/23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18/04/23
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	12/04/23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/03/23
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	24/02/23
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	29/12/22
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	29/12/22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	28/12/22
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07/10/22
H-CYTE, Inc. announced that it has received $0.225 million in funding	29/09/22
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days	19/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Innoveren Scientific Inc.

Actions

IVRN

US4041243076

Autres langues

Filtres